01419 HUMAN HEALTH
- 1.020
- +0.010+0.99%
HUMAN HEALTH News
HUMAN HEALTH: 2024 Interim Report
Yingjian Healthcare (01419) announced interim results. Profit attributable to shareholders of HK$2.033 million decreased by 92.53% year-on-year
Yingjian Healthcare (01419) announced results for the six months ended December 31, 2023, and the group achieved acceptance during the period...
HUMAN HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
Yingjian Healthcare (01419.HK) Board of Directors Approves Interim Results on February 27
Glonghui, Feb. 15 | Yingjian Healthcare (01419.HK) announced that the company's board of directors meeting will be held on February 27, 2024 (Tuesday) on the 12th floor of Enterprise Square Phase 2, 3 Sheung Yuet Road, Kowloon Bay, Kowloon Bay, Hong Kong, to (among others) approve the interim results and announcements of the company and its subsidiaries for the six months ended 31 December 2023, and consider the proposal to pay an interim dividend (if any).
Human Health Warns of Significant Decline in Fiscal H1 Profit
Human Health Holdings (HKG:1419) expects an attributable profit of up to HK$23 million for the six months ended Dec. 31, 2023, versus HK$268.1 million in the year-ago period. The healthcare services p
Yingjian Healthcare (01419.HK) Profit Alert: Profitability is expected to drop sharply in the medium term
Gelonghui, Feb. 8, 丨 Yingjian Healthcare (01419.HK) announced that it is expected to record profit attributable to company owners of not more than HK$23.0 million for the six months ending December 31, 2023, compared with the profit attributable to company owners of about HK$268.1 million compared to the same period last year. According to the data currently available, the reduction in profit attributable to company owners during this period was mainly due to (i) the Group's reduced revenue from general health services due to the continued decline in demand and supply of COVID-19 related prevention, testing, vaccination and outreach services; and (ii) the decline in general health service revenue resulting in gross profit
Changes in Hong Kong stocks | Yingjian Healthcare (01419) fell more than 7%, and revenue for the third quarter was about HK$141 million, down 66.6% year on year
Yingjian Medical (01419) fell by more than 7%. As of press release, it was down 7.55% to HK$0.98, with a turnover of HK$1,082 million.
Yingjian Healthcare (01419.HK) earned approximately HK$141 million in the first quarter
On December 12|Yingjian Healthcare (01419.HK) issued an announcement. According to the Group's current business data from July 1, 2023 to September 30, 2023, the Group's revenue for the quarter was approximately HK$141.2 million, compared with the Group's revenue of about HK$421.7 million for the same period last year. The decline in the Group's earnings for the quarter was mainly due to the continued decline in demand and supply of COVID-19 related prevention, testing, vaccination and outreach services, and the reduction in revenue from the Group's general health services.
Human Health to Allot Shares to Staffers, Service Providers
Human Health Holdings (HKG:1419) said it will allot shares to employees to incentivize their contribution to the group, retain talent and attract manpower. Shares issued to staffers will not exceed 10
HUMAN HEALTH: 2023 Annual Report
HUMAN HEALTH To Go Ex-Dividend On December 11th, 2023 With 0.16 HKD Dividend Per Share
September 27th - $HUMAN HEALTH(01419.HK)$ is trading ex-dividend on December 11th, 2023. Shareholders of record on December 12th, 2023 will receive 0.16 HKD dividend per share on December 29th, 20
Yingjian Healthcare (01419) Announces Annual Results Profit attributable to Company Owners was approximately HK$181 million, a year-on-year decrease of about 51.8%, and final dividend of 16 HK cents per share
Yingjian Healthcare (01419) announced results for the year ended June 30, 2023, with revenue of approximately $1,002 billion...
HUMAN HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2023; FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS; PROPOSED ADOPTION OF SHARE AWARD SCHEME; AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION
HUMAN HEALTH: DATE OF BOARD MEETING
Changes in Hong Kong stocks | Yingjian Healthcare opened 13.6% lower and expected annual profit attributable to shareholders to decrease by more than 50% year-on-year
Glonghui September 13 | Yingjian Healthcare opened 13.6% lower to HK$1.65. Yingjian Medical announced that for the year ending June 30, 2023, it is expected that the profit attributable to the company owners will not exceed HK$185 million. The profit due to owners of the company will be about HK$375 million for the same period last year, mainly due to the decline in demand for prevention, testing, vaccination and outreach services related to COVID-19, resulting in a decrease in revenue from general medical services; and a decline in gross profit due to a decrease in revenue from general medical services.
Human Health to See Lower Profit in Fiscal Year 2023
Human Health Holdings (HKG:1419) expects an attributable profit of up to HK$185 million for the year ended June 30, down from HK$375.3 million during the previous year, the healthcare services provide
Yingjian Healthcare (01419.HK) Profit Alert: Expected annual net profit of not more than HK$185 million
GLONGHUI, September 12丨Yingjian Healthcare (01419.HK) announced that for the year ending June 30, 2023, it is expected to record no more than HK$185 million in profit attributable to company owners. Comparatively, for the year ended June 30, 2022, the profit attributable to company owners was approximately HK$375.3 million. According to the announcement, the decrease in profit attributable to company owners during the year was mainly due to (i) a decrease in general medical service revenue due to a decline in demand for COVID-19 related prevention, testing, vaccination and outreach services; (ii) a decline in gross profit due to a decrease in general medical service revenue;
HUMAN HEALTH: PROFIT WARNING
Yingjian Healthcare: 2023 Interim Report
Human Health CFO Resigns
07:13 PM EST, 02/28/2023 (MT Newswires) -- Sat Chui Wan stepped down as chief financial officer and executive director of Human Health Holdings (HKG:1419) due to her other business engagement. Meanwh
Analysis
Price Target
No Data
